These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6128543)

  • 1. N-acetyltransferase phenotypes of bladder cancer patients in a low-risk population.
    Mommsen S; Sell A; Barfod N
    Lancet; 1982 Nov; 2(8309):1228. PubMed ID: 6128543
    [No Abstract]   [Full Text] [Related]  

  • 2. N-Acetyltransferase phenotype of patients with bladder cancer.
    Karakaya AE; Cok I; Sardas S; Gögüs O; Sardas OS
    Hum Toxicol; 1986 Sep; 5(5):333-5. PubMed ID: 3770769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of N-acetyltransferase polymorphism and environmental factors with bladder carcinogenesis. Study in a north German population.
    Hanssen HP; Agarwal DP; Goedde HW; Bucher H; Huland H; Brachmann W; Ovenbeck R
    Eur Urol; 1985; 11(4):263-6. PubMed ID: 4043164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of N-acetyltransferase phenotype in human susceptibility to bladder carcinogenic arylamines.
    Wolf H; Lower GM; Bryan GT
    Scand J Urol Nephrol; 1980; 14(2):161-5. PubMed ID: 7209420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark.
    Lower GM; Nilsson T; Nelson CE; Wolf H; Gamsky TE; Bryan GT
    Environ Health Perspect; 1979 Apr; 29():71-9. PubMed ID: 510245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of N-acetyltransferase phenotype in development of bladder neoplasms].
    Wolf H; Lower GM; Bryan GT
    Ugeskr Laeger; 1980 Feb; 142(6):382-5. PubMed ID: 7368384
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study.
    Wang CY; Jones RF; Debiec-Rychter M; Soos G; Haas GP
    Anticancer Res; 2002; 22(6B):3529-35. PubMed ID: 12552951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
    Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism and cancer susceptibility: evidence concerning acetyltransferases and cancer of the urinary bladder.
    Hein DW
    Bioessays; 1988 Dec; 9(6):200-4. PubMed ID: 3072000
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
    Cascorbi I; Roots I; Brockmöller J
    Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer.
    Cartwright RA; Glashan RW; Rogers HJ; Ahmad RA; Barham-Hall D; Higgins E; Kahn MA
    Lancet; 1982 Oct; 2(8303):842-5. PubMed ID: 6126711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biochemical indices of genetic susceptibility to cancer. Acetylation phenotype and bladder cancer.
    Hanke J; Krajewska B
    Pol J Occup Med; 1988; 1(4):306-11. PubMed ID: 2979565
    [No Abstract]   [Full Text] [Related]  

  • 13. N-Acetyltransferase phenotypes in the urinary bladder carcinogenesis of a low-risk population.
    Mommsen S; Barfod NM; Aagaard J
    Carcinogenesis; 1985 Feb; 6(2):199-201. PubMed ID: 3971485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association with bladder cancer.
    Wolf H
    Br Med J; 1979 Nov; 2(6201):1366. PubMed ID: 519454
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility in urinary bladder cancer: acetyltransferase phenotypes and related risk factors.
    Mommsen S; Aagaard J
    Cancer Lett; 1986 Aug; 32(2):199-205. PubMed ID: 3756846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic regulation of N-acetyltransferase in target organs of arylamine tumors: homologous expression in human and hamster bladder and colon.
    Hein DW
    Proc West Pharmacol Soc; 1991; 34():55-60. PubMed ID: 1788341
    [No Abstract]   [Full Text] [Related]  

  • 17. N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.
    Hosen MB; Islam J; Salam MA; Islam MF; Hawlader MZ; Kabir Y
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):78-84. PubMed ID: 25376209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acetylation phenotype in patients with cancer of the bladder. Preliminary report].
    Skretowicz J; Polakowski P; Jeromin L; Zasada M; Szymańska J; Krajewska B
    Med Pr; 1988; 39(4):241-5. PubMed ID: 3237058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
    Wu H; Wang X; Zhang L; Mo N; Lv Z
    Clin Genitourin Cancer; 2016 Apr; 14(2):122-9. PubMed ID: 26585839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary bladder cancer in a girl with a slow-acetylator genotype and treated with sulphasalazine.
    Espin Jaime MT; Moran Penco JM; Garcia Agundez JA; Caballero Loscos MJ; Sanjuan Rodriguez S; Botello Martinez F; Gomez de Tbjada R; Laguna Alvarez E; Benitez Rodriguez I
    Br J Urol; 1997 Jul; 80(1):151-2. PubMed ID: 9240200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.